volume 34 issue 35 pages 4225-4230

Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment

Publication typeJournal Article
Publication date2016-12-10
scimago Q1
wos Q1
SJR11.205
CiteScore38.9
Impact factor41.9
ISSN0732183X, 15277755
Cancer Research
Oncology
Abstract

In sharp contrast to many other cancer types, the incidence and mortality of endometrial cancer continue to grow. This unfortunate trend is, in no small part, a result of the worldwide obesity epidemic. More than half of endometrial cancers are currently attributable to obesity, which is recognized as an independent risk factor for this disease. In this review, we identify the molecular mechanisms by which obesity and adipose tissue contribute to the pathogenesis of endometrial cancer. We further discuss the impact of obesity on the clinical management of the disease and examine the development of rational behavioral and pharmaceutical interventions aimed at reducing endometrial cancer risk, improving cancer outcomes, and preserving fertility in an increasingly younger population of patients with endometrial cancer.

Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
Gynecologic Oncology
34 publications, 7.26%
Cancers
31 publications, 6.62%
Frontiers in Oncology
25 publications, 5.34%
Gynecologic Oncology Reports
12 publications, 2.56%
International Journal of Molecular Sciences
9 publications, 1.92%
American Journal of Obstetrics and Gynecology
6 publications, 1.28%
International Journal of Gynecological Cancer
6 publications, 1.28%
Medicine (United States)
5 publications, 1.07%
Frontiers in Pharmacology
5 publications, 1.07%
BMC Cancer
5 publications, 1.07%
International Journal of Gynecology and Obstetrics
5 publications, 1.07%
Nutrients
4 publications, 0.85%
Scientific Reports
4 publications, 0.85%
European Journal of Obstetrics, Gynecology and Reproductive Biology
4 publications, 0.85%
Journal of Obstetrics and Gynaecology Research
4 publications, 0.85%
Biomolecules
4 publications, 0.85%
Frontiers in Surgery
3 publications, 0.64%
Diagnostics
3 publications, 0.64%
Journal of Clinical Medicine
3 publications, 0.64%
Maturitas
3 publications, 0.64%
Australian and New Zealand Journal of Obstetrics and Gynaecology
3 publications, 0.64%
Journal of Gynecologic Oncology
3 publications, 0.64%
Journal of the National Cancer Institute
3 publications, 0.64%
Cancer Epidemiology Biomarkers and Prevention
3 publications, 0.64%
Discover Oncology
3 publications, 0.64%
Clinical and Experimental Obstetrics and Gynecology
3 publications, 0.64%
Future Oncology
2 publications, 0.43%
Oncotarget
2 publications, 0.43%
Biomedicines
2 publications, 0.43%
5
10
15
20
25
30
35

Publishers

20
40
60
80
100
120
Elsevier
116 publications, 24.79%
Springer Nature
78 publications, 16.67%
MDPI
71 publications, 15.17%
Frontiers Media S.A.
41 publications, 8.76%
Wiley
31 publications, 6.62%
Taylor & Francis
19 publications, 4.06%
Ovid Technologies (Wolters Kluwer Health)
16 publications, 3.42%
Cold Spring Harbor Laboratory
10 publications, 2.14%
Oxford University Press
8 publications, 1.71%
American Association for Cancer Research (AACR)
6 publications, 1.28%
American Society of Clinical Oncology (ASCO)
4 publications, 0.85%
Bioscientifica
3 publications, 0.64%
Impact Journals
3 publications, 0.64%
Spandidos Publications
3 publications, 0.64%
SAGE
3 publications, 0.64%
Georg Thieme Verlag KG
3 publications, 0.64%
Edizioni Minerva Medica
3 publications, 0.64%
Hindawi Limited
3 publications, 0.64%
IntechOpen
3 publications, 0.64%
BMJ
3 publications, 0.64%
IMR Press
3 publications, 0.64%
Mary Ann Liebert
2 publications, 0.43%
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy
2 publications, 0.43%
Research Square Platform LLC
2 publications, 0.43%
Bentham Science Publishers Ltd.
1 publication, 0.21%
International Union of Crystallography (IUCr)
1 publication, 0.21%
Portland Press
1 publication, 0.21%
1 publication, 0.21%
Public Library of Science (PLoS)
1 publication, 0.21%
20
40
60
80
100
120
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
469
Share
Cite this
GOST |
Cite this
GOST Copy
Onstad M. A., Schmandt R. E., Lu K. H. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment // Journal of Clinical Oncology. 2016. Vol. 34. No. 35. pp. 4225-4230.
GOST all authors (up to 50) Copy
Onstad M. A., Schmandt R. E., Lu K. H. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment // Journal of Clinical Oncology. 2016. Vol. 34. No. 35. pp. 4225-4230.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1200/jco.2016.69.4638
UR - https://doi.org/10.1200/jco.2016.69.4638
TI - Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
T2 - Journal of Clinical Oncology
AU - Onstad, Michaela A.
AU - Schmandt, Rosemarie E.
AU - Lu, Karen H.
PY - 2016
DA - 2016/12/10
PB - American Society of Clinical Oncology (ASCO)
SP - 4225-4230
IS - 35
VL - 34
PMID - 27903150
SN - 0732-183X
SN - 1527-7755
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2016_Onstad,
author = {Michaela A. Onstad and Rosemarie E. Schmandt and Karen H. Lu},
title = {Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment},
journal = {Journal of Clinical Oncology},
year = {2016},
volume = {34},
publisher = {American Society of Clinical Oncology (ASCO)},
month = {dec},
url = {https://doi.org/10.1200/jco.2016.69.4638},
number = {35},
pages = {4225--4230},
doi = {10.1200/jco.2016.69.4638}
}
MLA
Cite this
MLA Copy
Onstad, Michaela A., et al. “Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.” Journal of Clinical Oncology, vol. 34, no. 35, Dec. 2016, pp. 4225-4230. https://doi.org/10.1200/jco.2016.69.4638.